Bianca Rocca: Personalized Cardiovascular Pharmacotherapy in the September 2026 EHJ Issue
Bianca Rocca, Editor in Chief at European Heart Journal Cardiovascular Pharmacotherapy, shared on LinkedIn:
“New Issue Alert: EHJ Cardiovascular Pharmacotherapy (September 2026)
This issue explores the transition from universal evidence to personalised cardiovascular pharmacotherapy, spanning trial heterogeneity, precision anticoagulation, medication adherence, drug safety, and complex pharmacokinetic challenges across diverse patient populations.
Highlights include an editorial on contextual pharmacotherapy, thought provoking discussions on inconsistency across pharmacological trials, new perspectives on extended anticoagulation for cancer associated thrombosis, machine learning approaches to statin adherence, a comprehensive review of hydroxychloroquine cardiotoxicity, and an in depth analysis of pharmacokinetics in Fontan circulation.”
Stay updated with Hemostasis Today.
-
Nov 13, 2026, 03:21Abdul Muqtadir Abbasi: Iron Deficiency Beyond Anemia and the Importance of Finding the Cause
-
Nov 13, 2026, 03:05Marc Carrier: Aspirin vs Anticoagulants for VTE Prevention After Joint Replacement
-
Nov 13, 2026, 02:28Julia Sjöberg: ROCK1 Inhibition and Red Blood Cell Recovery After Chemotherapy
-
Nov 13, 2026, 02:07Tonie Reincke: Understanding Deep Vein Thrombosis and Vascular Health
-
Nov 13, 2026, 01:52Akshita Singh: The Remarkable Process of Blood Clotting
-
Nov 12, 2026, 22:52Milka Koupenova: The Role of Platelet RIG-I in Regulating Thrombotic Responses
-
Nov 12, 2026, 22:50Arun V J: Why Has India Still Not Achieved 100% Voluntary Blood Donation?
-
Nov 12, 2026, 22:49Sickle Cell Disease Deserves to Be Prioritised in Ghana – ISCC
-
Nov 12, 2026, 22:47Samir Kumar Beura: Delighted to Serve as a Topic Editor for a Research Topic in Frontiers in Neuroscience